Management Team

Jeff Reich MD




Jeffrey B Reich, MD  has over 30 years of experience in the life sciences. For >20 years he was a portfolio manager overseeing healthcare related investments at Merlin BioMed and Cramer Rosenthal McGlynn. He was a founding board member of Neurologix, the first CNS directed gene therapy company. Prior to going to Wall St, Dr Reich was an Assistant Professor of Neurology and Neuroscience at the Weill Cornell Medical Center and an Attending Neurologist at the The New York Presbyterian Hospital. He has participated in numerous NIH and industry sponsored clinical drug trials. Dr. Reich received his BS from Binghamton University and MD from the Weill Cornell School of Medicine.

Annie Pasternak

Chief Operating Officer


Annie Pasternak is our Chief Operating Officer. Prior to Sparian, Annie was a consultant at ClearView Healthcare Partners advising biotech and pharmaceutical companies on pre-clinical, clinical, commercial, and pricing / market access strategies. Along with her industry experience, she brings in-depth expertise on the arylepoxamide series having worked and published on the foundational science for SBS-1000. Annie received an honors Bachelor's degree in neuroscience from Dartmouth College

Scientific Co-Founders


Gavril Pasternak MD PhD

Company and Scientific


Anne Burnett Tandy Chair of Neurology

Member and Laboratory Head

Molecular Pharmacology Program and Department of Neurology at MSK

Professor of Neurology, Neuroscience, Pharmacology and Psychiatry at Weill Cornell Medical College


Ying-Xian Pan MD PhD

Scientific Co-Founder


Dept of Anesthesiology

Rutgers, New Jersey Medical School


Susruta Majumdar PhD

Scientific Co-Founder

Associate Professor of Pharmacology and Pharmaceutical Sciences

Center for Clinical Pharmacology

St. Louis College of Pharmacy

Washington University School of Medicine St. Louis, MO